.Sanofi has actually brought in an overdue entrance to the radioligand event, paying one hundred tho...
.After F2G's very first effort to get a new class of antifungal to market was wrecked by the FDA, th...
.Moderna has actually vowed to cut R&D spending through $1.1 billion by 2027. The decision to shr...
.Merely 4 months after Sanofi wager $80 million in beforehand cash on Key Therapies' losmapimod, the...
.Cancer cells company Oncternal Therapies is folding all its professional tests and giving up team, ...
.Roche is holding out chances that its own injectable weight problems prospect could at some point s...
.Novo Nordisk has actually lifted the cover on a period 1 trial of its own oral amylin and also GLP-...
.Just a handful of short full weeks after winning an FDA Fast Track tag for its investigational BTK ...
.Shortly after a positive data drop for Eli Lilly's efsitora alfa, the Indianapolis-based firm is on...
.BridgeBio Pharma is slashing its own gene treatment budget plan and also drawing back from the moda...